|Change: offered +53% / raised +72% / placed 72%|
|XDATA – December 7th 2015|
|Accolade‘s $35 million equity financing round increased by 53% to cap at $53.6 million. An additional $16.1 million worth of securities was placed by the company with three investors since the company last released data last July. This brings to $38.6 million the amount raised from the five backers who subscribed to the offering. The subscription is structured to close once the 28% left is fully subscribed or next July at the latest. The company closed three unregistered private placements which raised an estimated $53.72 million.|
|Accolade markets and develops a consumer healthcare engagement and influence platform for large self-insured employers and payer organizations. The platform helps consumers navigate the complex world of healthcare and benefits, find the right providers and get the right care the first time. Investors include Accretive, Carrick Capital Partners, Oak Hill Capital Partners, Comcast Ventures, Independence Health Group, and McKesson Ventures.|
|The company is headquartered in Plymouth Meeting PA. Accolade elected to keep its revenues undisclosed.
The executive team includes Debbie Cohen, Rajeev Singh, Steve Barnes and Thomas K Spann.
The board of directors includes Edgar Bronfman, J Michael Cline, James C Madden V, John W Rowe, Mark MacTas, Michael T Yang, Sheila Burke, Thomas J Neff and William Frist.
The company has raised an estimated total of $92.32 million via private unregistered security offerings.
Status: Intermediary close
Industry: Other Health Care
Amount offered: $53.6 million
Amount placed: $38.6 million
SEC filing: Source
First sale: 07-06-2015
Data as of: 12-07-2015